Are We Missing the Opportunity to Disseminate GOLD Recommendations Through AECOPD Discharge Letters?

References

• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Ford ES. Trends in mortality from chronic obstructive pulmonary disease among adults in the United States. Chest. 2015;148(4):962–970. doi:10.1378/chest.14-2311.Trends
   PubMed Web of Science ®Google Scholar
• World Health Organization. Chronic obstructive pulmonary disease (COPD); 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed May 23, 2023.
   Google Scholar
• Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. doi:10.1016/S2213-2600(21)00511-7
   PubMed Web of Science ®Google Scholar
• Gross NJ, Barnes PJ. New therapies for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(2):159–166. doi:10.1164/rccm.201610-2074PP
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for th eDiagnosis, management and prevention of chronic obstructive pulmonary disease (2023 Report); 2023. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed May 23, 2023.
   Google Scholar
• Rodriguez-Roisin R, Rabe KF, Vestbo J, Vogelmeier C, Agustí A. Global initiative for chronic obstructive lung disease (GOLD) 20th Anniversary: a brief history of time. Eur Respir J. 2017;50:1. doi:10.1183/13993003.00671-2017
   Web of Science ®Google Scholar
• Glaab T, Vogelmeier C, Hellmann A, Buhl R. Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany. Int J COPD. 2012;7:101–108. doi:10.2147/COPD.S27887
   Google Scholar
• Marmy JL, Diedrich JP, Cadus C, et al. Adherence to GOLD recommendations among Swiss pulmonologists and general practitioners. COPD J Chronic Obstr Pulm Dis. 2020;18(1):9–15. doi:10.1080/15412555.2020.1859469
   Web of Science ®Google Scholar
• Palmiotti GA, Lacedonia D, Schino P, et al. Adherence to GOLD Italy.pdf; 2018:2455–2462.
   Google Scholar
• Tzanakis N, Koulouris N, Dimakou K, et al. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study. BMC Pulm Med. 2021;21(1):1–9. doi:10.1186/s12890-021-01576-6
   PubMed Web of Science ®Google Scholar
• Rajnoveanu RM, Rajnoveanu AG, Ardelean AB, et al. Pulmonologists adherence to the chronic obstructive pulmonary disease gold guidelines: a goal to improve. Med. 2020;56(9):1–13. doi:10.3390/medicina56090422
   Google Scholar
• Albitar HAH, Iyer VN. Adherence to global initiative for chronic obstructive lung disease guidelines in the real world: current understanding, barriers, and solutions. Curr Opin Pulm Med. 2020;26(2):149–154. doi:10.1097/MCP.0000000000000655
   PubMed Web of Science ®Google Scholar
• Surani S, Aiyer A, Eikermann S, et al. Adoption and adherence to chronic obstructive pulmonary disease GOLD guidelines in a primary care setting. SAGE Open Med. 2019;7:205031211984222. doi:10.1177/2050312119842221
   Web of Science ®Google Scholar
• Maniscalco M, Martucci M, Fuschillo S, de Felice A, D’Anna SE, Cazzola M. A case scenario study on adherence to COPD GOLD recommendations by general practitioners in a rural area of southern Italy: the “progetto PADRE”. Respir Med. 2020;170:105985. doi:10.1016/j.rmed.2020.105985
   PubMed Web of Science ®Google Scholar
• Yawn BP, Wollan PC. Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J COPD. 2008;3(2):311–317. doi:10.2147/copd.s2486
   Google Scholar
• Sehl J, O’Doherty J, O’Connor R, O’Sullivan B, O’Regan A. Adherence to COPD management guidelines in general practice? A review of the literature. Ir J Med Sci. 2018;187(2):403–407. doi:10.1007/s11845-017-1651-7
   PubMed Web of Science ®Google Scholar
• Jochmann A, Neubauer F, Miedinger D, et al. General practitioners’ adherence to the COPD GOLD guidelines: baseline data from the Swiss COPD Cohort Study. Swiss Med Wkly. 2010;140:1–8. doi:10.4414/smw.2010.13053
   Web of Science ®Google Scholar
• Jiang YQ, Zhu YX, Chen XL, et al. Impact of adherence to GOLD guidelines on 6-minute walk distance, MRC dyspnea scale score, lung function decline, quality of life, and quality-adjusted life years in a Shanghai suburb. Genet Mol Res. 2015;14(3):8861–8870. doi:10.4238/2015.August.3.9
   PubMed Web of Science ®Google Scholar
• Mannino DM, Yu T-C, Zhou H, Higuchi K. GOLD-adherent prescribing and resource utilization journal.copdfoundation.org JCOPDF ©. J Copd F. 2015;2(3):223–235. doi:10.15326/jcopdf.2.3.2014.0151
   PubMedGoogle Scholar
• Kayyali R, Odeh B, Frerichs I, et al. COPD care delivery pathways in five European Union countries: mapping and health care professionals’ perceptions. Int J COPD. 2016;11(1):2831–2838. doi:10.2147/COPD.S104136
   Google Scholar
• Epstein D, Barak-Corren Y, Isenberg Y, Berger G. Clinical decision support system: a pragmatic tool to improve acute exacerbation of COPD discharge recommendations. COPD J Chronic Obstr Pulm Dis. 2019;16(1):18–24. doi:10.1080/15412555.2019.1593342
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Soler-Cataluña JJ, Miravitlles M; Global Initiative for Chronic Obstructive Lung Disease (2019 Report). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2019 report: future challenges. Arch Bronconeumol. 2020;56(2):65–67. goldcopd.org. doi:10.1016/j.arbr.2019.06.014
   PubMed Web of Science ®Google Scholar
• Fano V, D’Ovidio M, Del Zio K, et al. [The role of the quality of hospital discharge records on the comparative evaluation of outcomes: the example of chronic obstructive pulmonary disease (COPD)]. TT - Ruolo della qualita delle schede di dimissione ospedaliera nella valutazione co. Epidemiol Prev. 2012;36:172–179. Italian.
   PubMed Web of Science ®Google Scholar
• Migone C, O’Connor M, Kelly E, McDonnell TJ. Patients hospitalised with an acute exacerbation of COPD: is there a need for a discharge bundle of care? Ir Med J. 2015;108:9.
   Google Scholar
• Rea H, Kenealy T, Adair J, Robinson E, Sheridan N. Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. Int J COPD. 2011;6(1):527–532. doi:10.2147/COPD.S24133
   Google Scholar
• Fernández-Villar A, Represas-Represas C, Mouronte-Roibás C, et al. Reliability and usefulness of spirometry performed during admission for COPD exacerbation. PLoS One. 2018;13(3):1–12. doi:10.1371/journal.pone.0194983
   Web of Science ®Google Scholar
• Loh CH, Genese FA, Kannan KK, Lovings TM, Peters SP, Ohar JA. Spirometry in hospitalized patients with acute exacerbation of COPD accurately predicts post discharge airflow obstruction. Chronic Obstr Pulm Dis. 2018;5(2):124–133. doi:10.15326/jcopdf.5.2.2017.0169
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963. doi:10.1136/thoraxjnl-2011-201518
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/nejmoa0909883
   PubMed Web of Science ®Google Scholar
• McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population. Respir Med. 2015;109(2):228–237. doi:10.1016/j.rmed.2014.12.006
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671. doi:10.1164/rccm.201104-0597OC
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Calle M, Molina J, et al. Spanish COPD Guidelines (GesEPOC) 2021: updated Pharmacological treatment of stable COPD. Arch Bronconeumol. 2022;58(1):69–81. doi:10.1016/j.arbres.2021.03.005
   PubMed Web of Science ®Google Scholar
• Proboszcz M, Mycroft K, Paplinska-Goryca M, et al. Relationship between blood and induced sputum eosinophils, bronchial hyperresponsiveness and reversibility of airway obstruction in mild-to-moderate chronic obstructive pulmonary disease. COPD J Chronic Obstr Pulm Dis. 2019;16(5–6):354–361. doi:10.1080/15412555.2019.1675150
   PubMed Web of Science ®Google Scholar
• Hastie AT, Martinez FJ, Curtis JL, et al. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(12):956–967. doi:10.1016/S2213-2600(17)30432-0
   PubMed Web of Science ®Google Scholar
• Bogart M, Glassberg MB, Reinsch T, Stanford RH. Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care setting. Respir Med. 2018;145:138–144. doi:10.1016/j.rmed.2018.10.013
   PubMed Web of Science ®Google Scholar
• Mannino D, Bogart M, Germain G, et al. Benefit of prompt versus delayed use of single-inhaler fluticasone Furoate/Umeclidinium/ Vilanterol (FF/UMEC/VI) following a COPD exacerbation. Int J COPD. 2022;17:491–504. doi:10.2147/COPD.S337668
   Google Scholar
• van Eerd EAM, van der Meer RM, van Schayck OCP, Kotz D. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;2016:8. doi:10.1002/14651858.CD010744.pub2
   Google Scholar
• Reis AJ, Alves C, Furtado S, Ferreira J, Drummond M, Robalo-Cordeiro C. COPD exacerbations: management and hospital discharge. Pulmonology. 2018;24(6):345–350. doi:10.1016/j.pulmoe.2018.06.006
   PubMed Web of Science ®Google Scholar
• Hopkinson NS, Englebretsen C, Cooley N, et al. Designing and implementing a COPD discharge care bundle. Thorax. 2012;67(1):90–92. doi:10.1136/thoraxjnl-2011-200233
   PubMed Web of Science ®Google Scholar
• Jácome C, Marques A. Pulmonary rehabilitation for mild COPD: a systematic review. Respir Care. 2014;59(4):588–594. doi:10.4187/respcare.02742
   PubMed Web of Science ®Google Scholar
• Jones SE, Green SA, Clark AL, et al. Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax. 2014;69(2):181–182. doi:10.1136/thoraxjnl-2013-204227
   PubMed Web of Science ®Google Scholar
• Sharma G, Kuo YF, Freeman JL, Zhang DD, Goodwin JS. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med. 2010;170(18):1664–1670. doi:10.1001/archinternmed.2010.345
   PubMed Web of Science ®Google Scholar
• Rachel G, Amalia L, Kalcheim DO, Karp Erez MN, Maimon N. The association between hospital readmission and pulmonologist follow-up visits in patients with chronic obstructive pulmonary disease. Chest. 2015;148(2):375–381. doi:10.1378/chest.14-1453
   PubMed Web of Science ®Google Scholar
• Dummer J, Stokes T. Improving continuity of care of patients with respiratory disease at hospital discharge. Breathe. 2020;16(3):1–8. doi:10.1183/20734735.0161-2020
   Web of Science ®Google Scholar
• Ospina MB, Mrklas K, Deuchar L, et al. A systematic review of the effectiveness of discharge care bundles for patients with COPD. Thorax. 2017;72(1):31–39. doi:10.1136/thoraxjnl-2016-208820
   PubMed Web of Science ®Google Scholar
• Gómez-Angelats E, Sánchez C. Care bundles after discharging patients with chronic obstructive pulmonary disease exacerbation from the emergency department. Med Sci. 2018;6(3):63. doi:10.3390/medsci6030063
   Google Scholar
• Zafar MA, Loftus TM, Palmer JP, et al. COPD care bundle in emergency department observation unit reduces emergency department revisits. Respir Care. 2020;65(1):1–10. doi:10.4187/respcare.07088
   PubMed Web of Science ®Google Scholar
• Jennings JH, Thavarajah K, Mendez MP, Eichenhorn M, Kvale P, Yessayan L. Predischarge bundle for patients with acute exacerbations of COPD to reduce readmissions and ED visits: a randomized controlled trial. Chest. 2015;147(5):1227–1234. doi:10.1378/chest.14-1123
   PubMed Web of Science ®Google Scholar
• Cousse S, Gillibert A, Salaün M, Thiberville L, Cuvelier A, Patout M. Efficacy of a home discharge care bundle after acute exacerbation of COPD. Int J COPD. 2019;14:289–296. doi:10.2147/COPD.S178147
   Google Scholar